We are pleased to share that Aenitis has been featured in Biotech et Finances!
Our CEO, Emmanuel Vincent, spoke with Guillaume Mollaret about our recent successful fundraising to redefine bioproduction with our unique acoustofluidic technology.
During the discussion, Emmanuel Vincent also highlighted the addition of two new members to our Strategic Board and the significant benefits our technology brings to biomanufacturing, including increased yields, reduced costs and improved cell quality.
Headline : « AENITIS: DE L’ACOUSTIQUE CELLULAIRE À L’HARMONIQUE DES FONDS »
Read the full article on Biotech et Finances: https://biotech-finances.com/?s=aenitis
